Surmodics Inc.

NASDAQ: SRDX · Real-Time Price · USD
38.28
0.64 (1.70%)
At close: Aug 15, 2025, 3:14 PM

Surmodics Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
120.8M 121.58M 125.45M 126.08M 120.82M 142.96M 138.2M 132.58M 130.6M 102.97M 101.88M 99.95M 97.93M 96.95M 105.84M 105.14M 103.71M 106.72M 94.55M
Cost of Revenue
32.51M 33.25M 33.39M 43.44M 51.5M 60.33M 71.02M 71.56M 72.68M 72.64M 72.8M 70.95M 67.98M 67.22M 65.45M 63.91M 65.71M 66.13M 64.78M
Gross Profit
88.3M 88.33M 92.05M 82.64M 69.32M 82.63M 67.19M 61.02M 57.92M 30.33M 29.08M 29M 29.95M 29.73M 40.4M 41.23M 38M 40.59M 29.76M
Operating Income
-12.35M -12.47M -7.8M -5.64M -7.48M 19.3M 13.34M 6.43M 2.27M -26.28M -25.88M -22.09M -15.97M -11.21M 3.17M 6.7M 5.2M 8.75M -892K
Interest Income
518K 253K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-14.69M -14.57M -9.73M -7.51M -9.16M 17.3M 9.77M 2.49M -1.52M -29.35M -26.98M -22.49M -16.26M -11.59M 2.93M 6.35M 4.83M 8.55M -1.46M
Net Income
-17.63M -19.86M -14.41M -11.54M -1.4M 13.5M 5.52M -1.54M -22.96M -35.95M -32.3M -27.27M -12.84M -10.47M 1.7M 4.24M 1.58M 7.33M 701K
Selling & General & Admin
62.55M 61.42M 59.47M 56.84M 55.06M 51.31M 51.19M 51.89M 52.86M 52.84M 50.98M 46.94M 41.02M 36.05M 32.85M 30.68M 30.11M 29.65M 28.47M
Research & Development
11.76M 18.38M 25.42M 31.34M 38.35M 31.25M 23.44M 16.71M 9.1M 8.58M 8.46M 9.08M 9.86M 10.71M 11.57M 11.88M 21.8M 32.13M 40.91M
Other Expenses
26.34M 21M 14.97M 108K -16.61M -15.78M -17.33M -10.56M -2.86M -4.81M -4.48M 11.23M 12.28M 13.95M 15.74M 13.37M 13.36M 7K -882K
Operating Expenses
100.64M 100.8M 99.86M 88.29M 76.81M 64.17M 54.68M 55.43M 56.49M 56.61M 54.96M 51.09M 45.33M 39.89M 36.17M 33.47M 32.34M 31.84M 30.65M
Interest Expense
3.49M 3.5M 3.53M 3.54M 3.55M 3.56M 3.56M 3.49M 2.78M 2.04M 1.29M 598K 542K 456K 386K 310K 212K 182K 153K
Selling & Marketing Expenses
n/a n/a n/a n/a -3K -3K n/a n/a 3K 3K n/a n/a 842K 842K 842K 842K -13.79M -13.79M -13.79M
Cost & Expenses
133.15M 134.05M 133.25M 131.72M 128.3M 124.5M 125.7M 126.99M 129.17M 129.26M 127.76M 122.04M 113.31M 107.11M 101.62M 97.38M 98.05M 97.97M 95.44M
Income Tax Expense
2.94M 5.29M 4.68M 4.04M -7.76M 3.8M 4.25M 4.02M 21.44M 6.61M 5.32M 4.78M -3.43M -1.12M 1.24M 2.11M 3.25M 1.23M -2.16M
Shares Outstanding (Basic)
14.28M 14.28M 14.23M 14.19M 14.17M 14.15M 14.1M 14.06M 14.05M 14.03M 13.98M 13.91M 13.78M 13.92M 13.88M 13.84M 13.7M 13.75M 13.67M
Shares Outstanding (Diluted)
14.28M 14.28M 14.23M 14.19M 14.17M 14.18M 14.1M 14.15M 14.07M 14.03M 13.98M 13.94M 13.93M 13.92M 13.88M 13.85M 13.84M 13.98M 13.67M
EPS (Basic)
-1.23 -1.39 -1.01 -0.81 -0.09 0.96 0.39 -0.11 -1.65 -2.58 -2.32 -1.96 -0.92 -0.75 0.13 0.31 0.11 0.53 0.05
EPS (Diluted)
-1.23 -1.39 -1.01 -0.81 -0.1 0.95 0.38 -0.12 -1.65 -2.58 -2.32 -1.96 -0.92 -0.75 0.12 0.30 0.10 0.52 0.05
EBITDA
-8.23M -5.79M 972K 3.64M 3.07M 29.72M 22.74M 15.15M 10.51M -18M -16.21M -12.22M -6.04M -1.98M 11.84M 14.57M 12.42M 15.99M 5.94M
EBIT
-13.8M -13.67M -7.47M -5.24M -6M 20.47M 13.33M 5.98M 1.27M -27.3M -25.7M -21.89M -15.72M -11.14M 3.22M 6.69M 5.08M 8.7M -1.24M
Depreciation & Amortization
7.85M 7.88M 8.44M 8.88M 9.06M 9.25M 9.41M 9.17M 9.25M 9.3M 9.48M 9.67M 9.68M 9.16M 8.62M 8.02M 6.16M 6.1M 4.74M